Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
|
|
Mersana Therapeutics, Inc. (MRSN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| Huber Martin H. Jr. (President, CEO) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 9,102 options to buy
@ $1.26, valued at
$11.5k
|
|
| 10/04/2023 |
4
| Dere Willard H (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 11,011 shares
@ $0 |
|
| 10/04/2023 |
4
| Hege Kristen (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 9,523 options to buy
@ $1.26, valued at
$12k
|
|
| 10/04/2023 |
4
| Alleva Lawrence M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 14,047 options to buy
@ $1.26, valued at
$17.7k
|
|
| 10/04/2023 |
4
| MOTT DAVID M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 15,873 shares
@ $0 |
|
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/06/2023 |
4
| Alleva Lawrence M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 5,391 options to buy
@ $3.42, valued at
$18.4k
|
|
| 07/06/2023 |
4
| Huber Martin H. Jr. (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 4,477 options to buy
@ $3.42, valued at
$15.3k
|
|
| 07/06/2023 |
4
| Hege Kristen (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 3,654 options to buy
@ $3.42, valued at
$12.5k
|
|
| 07/06/2023 |
4
| Dere Willard H (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 4,217 shares
@ $0 |
|
| 07/06/2023 |
4
| MOTT DAVID M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 6,079 shares
@ $0 |
|
| 06/12/2023 |
4
| Hack Andrew A. F. (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 14,467 shares
@ $0
Granted 18,355 options to buy
@ $8.64, valued at
$158.6k
|
|
| 06/12/2023 |
4
| Diaz Allene M. (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 14,467 shares
@ $0
Granted 18,355 options to buy
@ $8.64, valued at
$158.6k
|
|
| 06/12/2023 |
4
| Hege Kristen (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 14,467 shares
@ $0
Granted 18,355 options to buy
@ $8.64, valued at
$158.6k
|
|
| 06/12/2023 |
4
| Huber Martin H. Jr. (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 14,467 shares
@ $0
Granted 18,355 options to buy
@ $8.64, valued at
$158.6k
|
|
| 06/12/2023 |
4
| MOTT DAVID M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 14,467 shares
@ $0
Granted 18,355 options to buy
@ $8.64, valued at
$158.6k
|
|
| 06/12/2023 |
4
| Alleva Lawrence M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 14,467 shares
@ $0
Granted 18,355 options to buy
@ $8.64, valued at
$158.6k
|
|
| 06/12/2023 |
4
| Dere Willard H (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 14,467 shares
@ $0
Granted 18,355 options to buy
@ $8.64, valued at
$158.6k
|
|
| 04/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2023 |
4
| Hege Kristen (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 3,451 options to buy
@ $4.25, valued at
$14.7k
|
|
| 04/05/2023 |
4
| Huber Martin H. Jr. (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 3,375 options to buy
@ $4.25, valued at
$14.3k
|
|
| 04/05/2023 |
4
| MOTT DAVID M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 4,866 shares
@ $0 |
|
| 04/05/2023 |
4
| Alleva Lawrence M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 4,525 options to buy
@ $4.25, valued at
$19.2k
|
|
| 04/05/2023 |
4
| Dere Willard H (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 3,375 shares
@ $0 |
|
| 01/18/2023 |
4
| Yang Arvin (SVP, Chief Medical Officer) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Sold 2,209 shares
@ $5.74, valued at
$12.7k
Granted 217,500 options to buy
@ $6.06, valued at
$1.3M
Granted 48,333 restricted stock units
@ $0
Exercised 7,084 restricted stock units
@ $0 |
|
| 01/18/2023 |
4
| Protopapas Anna (President & CEO) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Gifted 240,244 shares
@ $0
Gifted 240,244 shares
@ $0
Sold 17,346 shares
@ $5.74, valued at
$99.6k
Granted 562,500 options to buy
@ $6.06, valued at
$3.4M
Granted 125,000 restricted stock units
@ $0
Exercised 16,750 restricted stock units
@ $0
Exercised 21,250 restricted stock units
@ $0
Exercised 17,708 restricted stock units
@ $0 |
|
| 01/18/2023 |
4
| Mandelia Ashish (VP, Controller) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Sold 3,575 shares
@ $5.74, valued at
$20.5k
Granted 47,625 options to buy
@ $6.06, valued at
$288.6k
Granted 10,583 restricted stock units
@ $0
Exercised 4,784 restricted stock units
@ $0
Exercised 4,519 restricted stock units
@ $0
Exercised 833 restricted stock units
@ $0 |
|
| 01/18/2023 |
4
| MISRA TUSHAR (SVP, CMO) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Sold 458 shares
@ $5.74, valued at
$2.6k
Granted 127,500 options to buy
@ $6.06, valued at
$772.7k
Granted 28,333 restricted stock units
@ $0
Exercised 1,459 restricted stock units
@ $0 |
|
| 01/18/2023 |
4
| Lowinger Timothy B (SVP, Chief Sci.&Tech. Off.) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Sold 6,233 shares
@ $5.74, valued at
$35.8k
Granted 168,750 options to buy
@ $6.06, valued at
$1M
Granted 37,500 restricted stock units
@ $0
Exercised 4,792 restricted stock units
@ $0
Exercised 7,292 restricted stock units
@ $0
Exercised 7,917 restricted stock units
@ $0 |
|
| 01/18/2023 |
4
| DeSchuytner Brian (SVP, CFO) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Sold 5,131 shares
@ $5.74, valued at
$29.5k
Granted 180,000 options to buy
@ $6.06, valued at
$1.1M
Granted 40,000 restricted stock units
@ $0
Exercised 6,250 restricted stock units
@ $0
Exercised 6,250 restricted stock units
@ $0
Exercised 3,958 restricted stock units
@ $0 |
|
| 01/18/2023 |
4
| Carvajal Alejandra (SVP, Chief Legal Officer) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Sold 782 shares
@ $5.74, valued at
$4.5k
Granted 161,250 options to buy
@ $6.06, valued at
$977.2k
Granted 35,833 restricted stock units
@ $0
Exercised 2,500 restricted stock units
@ $0 |
|
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|